Nathaniel P. Morris is a resident physician at Stanford Hospital specializing in mental health. He recently penned a strongly worded op-ed for ScientificAmerican.com on the differences between how some in the medical community view marijuana and how the federal government regulates it.

“The federal government’s scheduling of marijuana bears little relationship to actual patient care,” he wrote in the essay published last week. “The notion that marijuana is more dangerous or prone to abuse than alcohol (not scheduled), cocaine (Schedule II), methamphetamine (Schedule II), or prescription opioids (Schedules II, III, and IV) doesn’t reflect what we see in clinical medicine.”

Here’s Morris’ money quote:

For most health care providers, marijuana is an afterthought.

We don’t see cannabis overdoses. We don’t order scans for cannabis-related brain abscesses. We don’t treat cannabis-induced heart attacks. In medicine, marijuana use is often seen on par with tobacco or caffeine consumption — something we counsel patients about stopping or limiting, but nothing urgent to treat or immediately life-threatening.

[Read more at The Washington Post]